← FDA DRUG APPROVALS

FDA ANDA · ANDA078763

LITHIUM CARBONATE

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA078763
TYPE
ANDA
ORIGINAL APPROVAL
2008-04-15
LATEST ACTION
2025-10-06
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

LITHIUM CARBONATEDiscontinued
LITHIUM CARBONATE 600MG · CAPSULE · ORAL

Approval history

2025-10-06Labeling · Supplement 10 · standardAP
2018-05-03Labeling · Supplement 9 · standardAP
2016-03-24Labeling · Supplement 5 · standardAP
2012-03-06Labeling · Supplement 2AP
2008-04-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →